Company Filing History:
Years Active: 2023-2024
Title: Mark Szewc: Innovator in Peptide Quantitation Assays
Introduction
Mark Szewc is a notable inventor based in Morgantown, WV (US). He has made significant contributions to the field of peptide quantitation, holding a total of 2 patents. His work focuses on methods for differentiating high molecular weight kininogen, which has important implications in biological research and diagnostics.
Latest Patents
Mark Szewc's latest patents include innovative methods for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK. These methods involve treating a biological sample with a protease to generate a variety of digested peptides. By measuring specific signature peptides, researchers can identify the presence of cleaved HMWK and/or full-length HMWK in a sample. This advancement enhances the accuracy of peptide quantitation assays, contributing to better understanding in the field.
Career Highlights
Mark Szewc is currently associated with Takeda Pharmaceutical Company Limited, where he applies his expertise in peptide quantitation. His work at Takeda has allowed him to collaborate with leading professionals in the field, furthering the development of innovative solutions in pharmaceutical research.
Collaborations
Some of his notable coworkers include Jiang Wu and Guodong Zhang. Their collaborative efforts have contributed to the advancement of research in peptide quantitation and related methodologies.
Conclusion
Mark Szewc's contributions to the field of peptide quantitation assays demonstrate his commitment to innovation and research. His patents and work at Takeda Pharmaceutical Company Limited highlight the importance of his findings in advancing scientific knowledge and applications.